- Pfizer $PFE held a webcast related to Rheumatoid Arthritis around the American College of Rheumatology meeting last week.
- Click here to download the slides deck (PDF).
- See below for a few helpful notes and figures related to the RA market
- Market size was $12.7b in 2010, projected to be $17.3b in 2015
- 4.6m patients in 2010, projected to be 5.2m in 2019 (US, France, Germany, Italy, Spain, UK, Japan)
- 20-40% of patients fail to achieve ACR20 with biologics, and response can be lost over time
- The bulk of the slide deck focused on tofacitinib, PFE's new RA drug that will soon be filed for approval